Chengdu Kanghua Biological Products Co., Ltd. (SHE:300841)
China · Delayed Price · Currency is CNY 60.89
+0.90 (1.50%)
Apr 21, 2026, 3:04 PM CST
SHE:300841 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 226.55 | 219.9 | 398.65 | 509.22 | 598.07 | 829.48 |
Depreciation & Amortization | 76.77 | 76.77 | 63.4 | 51.46 | 32.57 | 16.53 |
Other Amortization | 11.75 | 11.75 | 11.3 | 10.31 | 8.38 | 5.29 |
Loss (Gain) From Sale of Assets | 0.01 | 0.01 | 1.79 | 0.48 | 0.74 | 0.11 |
Asset Writedown & Restructuring Costs | 11.78 | 11.78 | 0.02 | - | - | - |
Loss (Gain) From Sale of Investments | -5.43 | -5.43 | 58.83 | 31.25 | -56.9 | -273.98 |
Provision & Write-off of Bad Debts | - | - | 15.16 | 8.6 | 34.09 | 8.35 |
Other Operating Activities | 46.05 | 15.15 | 20.22 | 7.74 | 13.07 | 2.17 |
Change in Accounts Receivable | 64.31 | 64.31 | 102.45 | -113.84 | -448.91 | -535.23 |
Change in Inventory | 27.99 | 27.99 | -4.98 | -21.52 | -56.86 | -57.53 |
Change in Accounts Payable | -37.73 | -37.73 | -90.03 | 95.7 | 61.35 | 124.72 |
Change in Other Net Operating Assets | - | - | - | -3.96 | 3.12 | 12.27 |
Operating Cash Flow | 417.27 | 379.71 | 572.24 | 573.98 | 194.99 | 130.33 |
Operating Cash Flow Growth | -8.69% | -33.65% | -0.30% | 194.37% | 49.62% | -64.73% |
Capital Expenditures | -57.59 | -70.79 | -144.3 | -157.27 | -419.23 | -314.94 |
Sale of Property, Plant & Equipment | 0.07 | 0.07 | 0.28 | 0.04 | 0 | 0.01 |
Investment in Securities | -282.68 | 208.32 | -198.88 | -6.5 | 6.25 | 108.75 |
Other Investing Activities | 10.81 | 9.75 | 1.04 | 0.35 | 0.52 | 4.65 |
Investing Cash Flow | -329.4 | 147.35 | -341.87 | -163.39 | -412.46 | -201.53 |
Short-Term Debt Issued | - | - | 237.78 | 221.75 | - | - |
Long-Term Debt Issued | - | 179.79 | - | - | 155.93 | - |
Total Debt Issued | 120 | 179.79 | 237.78 | 221.75 | 155.93 | - |
Short-Term Debt Repaid | - | - | -241.75 | -156.93 | - | - |
Long-Term Debt Repaid | - | -226.78 | - | -0.31 | -30 | - |
Total Debt Repaid | -251.23 | -226.78 | -241.75 | -157.24 | -30 | - |
Net Debt Issued (Repaid) | -131.23 | -46.99 | -3.97 | 64.52 | 125.93 | - |
Issuance of Common Stock | - | - | - | - | 5.17 | - |
Repurchase of Common Stock | - | - | -200 | - | - | - |
Common Dividends Paid | -132.88 | -136.43 | -267.83 | -71.63 | -136.82 | -90 |
Other Financing Activities | - | - | - | - | -67.84 | -57.4 |
Financing Cash Flow | -264.11 | -183.42 | -471.79 | -7.12 | -73.56 | -147.4 |
Foreign Exchange Rate Adjustments | -0.03 | 0.04 | 1.77 | -0.07 | 0.11 | -0.01 |
Net Cash Flow | -176.28 | 343.68 | -239.65 | 403.41 | -290.92 | -218.61 |
Free Cash Flow | 359.68 | 308.92 | 427.94 | 416.71 | -224.24 | -184.61 |
Free Cash Flow Growth | 10.10% | -27.81% | 2.70% | - | - | - |
Free Cash Flow Margin | 29.98% | 26.52% | 29.89% | 26.42% | -15.50% | -14.28% |
Free Cash Flow Per Share | 2.77 | 2.38 | 3.25 | 3.12 | -1.67 | -1.37 |
Cash Income Tax Paid | 80.14 | 71.75 | 144.18 | 105.34 | 143.61 | 118.61 |
Levered Free Cash Flow | 282.98 | 222.9 | 278.84 | 140.63 | -311.18 | -314.21 |
Unlevered Free Cash Flow | 282.98 | 222.9 | 282.2 | 143.63 | -309.19 | -314.17 |
Change in Working Capital | 49.78 | 49.78 | 2.87 | -45.08 | -435.02 | -457.63 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.